Healthcare provider profile · identity verified

Alan Aspinall

Family Practice · MURRYSVILLE, PA · NPI 1992777395

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1018	280
Lisinopril	Lisinopril	441	120
Losartan Potassium	Losartan Potassium	406	113
Amlodipine Besylate	Amlodipine Besylate	337	98
Metoprolol Succinate	Metoprolol Succinate	333	95
Omeprazole	Omeprazole	285	82
Levothyroxine Sodium	Levothyroxine Sodium	281	79
Pantoprazole Sodium	Pantoprazole Sodium	250	65
Rosuvastatin Calcium	Rosuvastatin Calcium	226	75
Eliquis	Apixaban	218	40
Tamsulosin Hcl	Tamsulosin Hcl	215	64
Atenolol	Atenolol	182	52
Simvastatin	Simvastatin	169	44
Hydrochlorothiazide	Hydrochlorothiazide	167	51
Metformin Hcl Er	Metformin Hcl	159	48
Glimepiride	Glimepiride	154	39
Gabapentin	Gabapentin	151	46
Metformin Hcl	Metformin Hcl	133	39
Metoprolol Tartrate	Metoprolol Tartrate	131	36
Famotidine	Famotidine	130	42
Prednisone	Prednisone	119	74
Albuterol Sulfate Hfa	Albuterol Sulfate	106	42
Furosemide	Furosemide	105	39
Allopurinol	Allopurinol	99	31
Escitalopram Oxalate	Escitalopram Oxalate	99	32
Glipizide Er	Glipizide	93	28
Lorazepam	Lorazepam	89	30
Fluticasone Propionate	Fluticasone Propionate	86	36
Potassium Chloride	Potassium Chloride	82	26
Finasteride	Finasteride	78	24
Zolpidem Tartrate	Zolpidem Tartrate	77	17
Trazodone Hcl	Trazodone Hcl	73	24
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	19
Citalopram Hbr	Citalopram Hydrobromide	70	19
Alendronate Sodium	Alendronate Sodium	67	20
Carvedilol	Carvedilol	67	25
Paroxetine Hcl	Paroxetine Hcl	65	14
Sertraline Hcl	Sertraline Hcl	62	20
Clonazepam	Clonazepam	60	11
Clopidogrel	Clopidogrel Bisulfate	60	23
Felodipine Er	Felodipine	59	19
Triamcinolone Acetonide	Triamcinolone Acetonide	59	33
Naproxen	Naproxen	55	17
Pioglitazone Hcl	Pioglitazone Hcl	55	17
Tradjenta	Linagliptin	54	15
Fluoxetine Hcl	Fluoxetine Hcl	53	16
Pravastatin Sodium	Pravastatin Sodium	53	15
Warfarin Sodium	Warfarin Sodium	53	12
Xarelto	Rivaroxaban	52	11
Azithromycin	Azithromycin	50	46
Doxazosin Mesylate	Doxazosin Mesylate	50	14
Meloxicam	Meloxicam	48	17
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	46	14
Donepezil Hcl	Donepezil Hcl	44	14
Duloxetine Hcl	Duloxetine Hcl	42	12
Mirtazapine	Mirtazapine	39	12
Alprazolam	Alprazolam	38	12
Methylprednisolone	Methylprednisolone	38	34
Colchicine	Colchicine	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	37	31
Spironolactone	Spironolactone	36	11
Tramadol Hcl	Tramadol Hcl	35	15
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Ibuprofen	Ibuprofen	34	18
Esomeprazole Magnesium	Esomeprazole Magnesium	33	12
Jardiance	Empagliflozin	33	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Bupropion Hcl Sr	Bupropion Hcl	31	13
Cephalexin	Cephalexin	31	24
Sumatriptan Succinate	Sumatriptan Succinate	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	14
Synthroid	Levothyroxine Sodium	30	suppressed
Valsartan	Valsartan	30	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	28	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	25
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Ventolin Hfa	Albuterol Sulfate	27	11
Baclofen	Baclofen	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Digoxin	Digoxin	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	suppressed
Trulicity	Dulaglutide	24	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Celecoxib	Celecoxib	22	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	22	suppressed
Entresto	Sacubitril/Valsartan	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Amoxicillin	Amoxicillin	18	13
Arnuity Ellipta	Fluticasone Furoate	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Levetiracetam	Levetiracetam	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Propranolol Hcl	Propranolol Hcl	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	13	suppressed
Lovastatin	Lovastatin	13	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	13	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Tiotropium Bromide	Tiotropium Bromide	12	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Epinephrine	Epinephrine	11	11
Fluticasone Propionate Hfa	Fluticasone Propionate	11	suppressed
Ipratropium Bromide	Ipratropium Bromide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error